Between pathways and networks lies context: Implications for precision medicine

Ted Laderas, Guanming Wu, Shannon McWeeney

Research output: Contribution to journalArticle

Abstract

Precision medicine, broadly defined as considering individual variability in genes, environment, and lifestyle for each person in disease prevention and selection of suitable medical intervention, shows strong promise in the treatment of cancer. Selecting therapies is complicated by multiple routes to gene dysregulation, which manifest in the individual patient within the many different types of genomic measurements. Additionally, multiple mutations exist in patients, a phenomenon known as oncogenic collaboration, which further complicates the selection of therapy. In this article, we discuss current approaches using biological pathways and networks to unify the many types of OMICs data. We argue that a contextual approach combining cancer pathways and networks could lead to a proper understanding of the biology of this significant disease.

Original languageEnglish (US)
Pages (from-to)253-263
Number of pages11
JournalScience Progress
Volume98
Issue number3
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

Precision Medicine
Genes
Life Style
Neoplasms
Therapeutics
Mutation

Keywords

  • Genomic alterations
  • Networks
  • Pathways
  • Precision medicine
  • Targeted drug therapy

ASJC Scopus subject areas

  • General

Cite this

Between pathways and networks lies context : Implications for precision medicine. / Laderas, Ted; Wu, Guanming; McWeeney, Shannon.

In: Science Progress, Vol. 98, No. 3, 01.09.2015, p. 253-263.

Research output: Contribution to journalArticle

@article{62b61939c6bf4c98b5eb127ce520c87a,
title = "Between pathways and networks lies context: Implications for precision medicine",
abstract = "Precision medicine, broadly defined as considering individual variability in genes, environment, and lifestyle for each person in disease prevention and selection of suitable medical intervention, shows strong promise in the treatment of cancer. Selecting therapies is complicated by multiple routes to gene dysregulation, which manifest in the individual patient within the many different types of genomic measurements. Additionally, multiple mutations exist in patients, a phenomenon known as oncogenic collaboration, which further complicates the selection of therapy. In this article, we discuss current approaches using biological pathways and networks to unify the many types of OMICs data. We argue that a contextual approach combining cancer pathways and networks could lead to a proper understanding of the biology of this significant disease.",
keywords = "Genomic alterations, Networks, Pathways, Precision medicine, Targeted drug therapy",
author = "Ted Laderas and Guanming Wu and Shannon McWeeney",
year = "2015",
month = "9",
day = "1",
doi = "10.3184/003685015X14368898634462",
language = "English (US)",
volume = "98",
pages = "253--263",
journal = "Science Progress",
issn = "0036-8504",
publisher = "Science Reviews Ltd",
number = "3",

}

TY - JOUR

T1 - Between pathways and networks lies context

T2 - Implications for precision medicine

AU - Laderas, Ted

AU - Wu, Guanming

AU - McWeeney, Shannon

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Precision medicine, broadly defined as considering individual variability in genes, environment, and lifestyle for each person in disease prevention and selection of suitable medical intervention, shows strong promise in the treatment of cancer. Selecting therapies is complicated by multiple routes to gene dysregulation, which manifest in the individual patient within the many different types of genomic measurements. Additionally, multiple mutations exist in patients, a phenomenon known as oncogenic collaboration, which further complicates the selection of therapy. In this article, we discuss current approaches using biological pathways and networks to unify the many types of OMICs data. We argue that a contextual approach combining cancer pathways and networks could lead to a proper understanding of the biology of this significant disease.

AB - Precision medicine, broadly defined as considering individual variability in genes, environment, and lifestyle for each person in disease prevention and selection of suitable medical intervention, shows strong promise in the treatment of cancer. Selecting therapies is complicated by multiple routes to gene dysregulation, which manifest in the individual patient within the many different types of genomic measurements. Additionally, multiple mutations exist in patients, a phenomenon known as oncogenic collaboration, which further complicates the selection of therapy. In this article, we discuss current approaches using biological pathways and networks to unify the many types of OMICs data. We argue that a contextual approach combining cancer pathways and networks could lead to a proper understanding of the biology of this significant disease.

KW - Genomic alterations

KW - Networks

KW - Pathways

KW - Precision medicine

KW - Targeted drug therapy

UR - http://www.scopus.com/inward/record.url?scp=84941796617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941796617&partnerID=8YFLogxK

U2 - 10.3184/003685015X14368898634462

DO - 10.3184/003685015X14368898634462

M3 - Article

C2 - 26601340

AN - SCOPUS:84941796617

VL - 98

SP - 253

EP - 263

JO - Science Progress

JF - Science Progress

SN - 0036-8504

IS - 3

ER -